CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Survivor Mom Companionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06318663
NCT06318663N/ACompleted

Survivor Moms' Companion: A Perinatal PTSD Program

State University of New York at Buffalo·interventional·Posted Mar 19, 2024·Updated Apr 9, 2025

In Brief

A clinical study evaluating Survivor Mom Companion for Posttraumatic Stress Symptom. Completed, enrolled 39 participants across 1 site.

Detailed Summary

The overall goal of the SMC is to help reduce posttraumatic stress symptomology for pregnant persons with a history of trauma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMar 19, 2024
Enrollment StartDec 12, 2023
Primary CompletionOct 11, 2024
Study CompletionNov 11, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.3 years ago

Interventions

Survivor Mom Companionother

Weekly intervention sessions will follow the survivor Moms' Companion manualized modules. One module each week. The module centers on reinforcement of information introduced in each previous module, then emotional support, and referrals to additional services or specialists as needed. Participants in each session will practice applying knowledge and skills using the module's vignettes. Process guides prompt inquiry about in vivo management of post-traumatic stress disorder reactions and emotional and interpersonal responses to events since the last session. Each module may require 45 minutes of self-study before each session and 45 minutes of in-session time spent with the interventionist.